Document:

stls_8k012010ex101.htm

    Exhibit
10.1

    
 

    UNIT
PURCHASE AND MUTUAL RELEASE AGREEMENT

    

    THIS UNIT PURCHASE AND MUTUAL RELEASE
AGREEMENT (this “Agreement”)
is effective as of January 21, 2010 (the “Effective
Date”) by and between St. Lawrence Seaway Corporation., a Delaware
corporation (“Seller”)
and T3 Therapeutics, LLC, a Delaware limited liability company (the “Company”).

    

    WHEREAS, the Seller is the beneficial
and record owner of 250 units of membership interest in the Company;
and

    

    WHEREAS, the Seller wishes to sell, and
the Company wishes to purchase, 250 units of membership interest in the Company
(the “Seller
Units”) in accordance with the Company’s Amended and Restated Operating
Agreement dated November 16, 2005, as amended from time to time (the “Operating
Agreement”), and the provisions of this Agreement; and

    

    WHEREAS, the Seller and the Company
have agreed to execute and deliver this Agreement to effect the sale and
purchase of the Seller Units.

    

    NOW, THEREFORE, in consideration of the
foregoing Recitals, and other good and valuable consideration, the receipt and
sufficiency of which is hereby acknowledged, the parties hereby agree as
follows:

    

    1.           Agreements.

    

    (a)           Sale and
Purchase.    As of the Effective Date, Seller hereby
sells, transfers, and assigns to the Company all of Seller’s right, title, and
interest in and to the Seller Units and the Company hereby acquires, receives,
and accepts the Seller Units and all right, title, and interest
therein.

    

    (b)           Deliveries.  The
parties will make the following deliveries as of the Effective
Date:

     

    (i)   Seller
shall deliver a bill of sale to the Company certified by the Chief Executive
Officer of the Seller in substantially the form annexed hereto as Exhibit
A;

    (ii)   the
Company shall pay to Seller the sum of $100,000 US by check or wire transfer in
immediately available funds (the “Payment
Amount”).

     

    (c)           Consideration.  The
Payment Amount is delivered in final satisfaction and settlement of all amounts
owed by the Company to Seller in connection with the Seller Units or otherwise,
and in consideration of Seller’s release below.  The parties agree
that the Payment Amount represents full and fair consideration for the Seller
Units and the other agreements herein.

    

    (d)           Resignations.  Seller
hereby resigns (or, as applicable, confirms and ratifies any resignation of its
designee(s)) from any and all positions as officer or director of the Company to
which Seller or its designee(s) have been appointed or elected.

    

    (e)           Operating
Agreement.  Seller hereby waives any rights it has or may have
under the Operating Agreement or otherwise regarding the sale, transfer,
redemption, or other disposition of the Seller Units, or any procedures relating
thereto, and acknowledges and agrees that, as of the Effective Date, Seller
shall no longer be a unitholder under the Operating Agreement or a party
thereto.

    

    
      
        1

      

      
        
          

        

      

      
         

      

    

    2.           Representations
and Warranties.

    

               (a)           Authorization;
Enforceability.  Each party hereto hereby represents and
warrants to the other party hereto that this Agreement has been approved and
authorized pursuant to all board and shareholder (or unitholder) approvals
required by law and by the articles of organization (or like document),
shareholders agreement (or like document), and other applicable agreements of
such party.   Each party hereby represents and warrants to the
other party that its signatory below is fully authorized to enter into the terms
of, and to execute this Agreement on behalf of such party.  Each party
hereby represents and warrants to the other party that upon its execution
hereof, this Agreement will constitute the valid and binding obligation of such
party, and will be fully enforceable against such party in accordance with its
terms.

     

    (b)           Acknowledgment of
Release.  The parties hereby acknowledge that this Agreement
includes a general release, and that they have had a full opportunity to be
represented in this matter by counsel, have had sufficient time to consult with
their counsel to the extent they deem necessary, have read this Agreement,
understand its provisions and have signed this Agreement knowingly and
voluntarily.

    

    (c)           Seller
Units.  Seller hereby represents and warrants to the Company
that: (i) Seller has good title to all of the Seller Units; (ii) the Seller
Units represent all of the equity interests held by Seller in the Company,
including, without limitation, all units of any class or series, all options,
all warrants, all puts and calls, and all other securities or instruments
convertible into securities of any kind whatsoever; (iii) Seller has full right
and power to sell the Seller Units; (iv) the Seller Units shall be transferred
free and clear of any lien, pledge, security interest, encumbrance, or claim of
any kind whatsoever; and (v) sale of the Seller Units will not violate any
agreement to which Seller is bound, or any court order by which Seller is bound,
or any provision of Seller’s articles of organization (or like document),
shareholders agreement (or like document), or other applicable agreements of
Seller.

    

    (d)           Company
Representation.  The Company represents and warrants that it is
not presently in negotiations with any party concerning any material strategic
partnership, affiliation, joint venture, acquisition, investment or other like
transaction.

    

    3.           Other
Agreements.

    

    (a)           Indemnification by the
Company.  From and after the Effective Date, the Company shall
indemnify and hold harmless Seller and the Seller’s officers, directors and employees
from and against any and all damages, losses, obligations, deficiencies,
claims, encumbrances, penalties, fines, costs and expenses or other liabilities,
including reasonable attorneys’ fees and expenses (collectively, “Indemnifiable
Losses”) which Seller or
its officers, directors or employees may suffer or incur, resulting from,
related to, or arising out of: (i) the inaccuracy of any representation or
warranty of the Company which is contained in or made pursuant to this
Agreement; or (ii) any material breach by the Company of any of its agreements
or obligations contained in or made pursuant to this Agreement.

    

    (b)           Indemnification by
Seller.  From and after the Effective Date, Seller shall
indemnify and hold harmless the Company and the Company’s officers, directors
and employees from and against any and all Indemnifiable Losses which the
Company or its officers, directors or employees may suffer or incur, resulting
from, related to, or arising out of: (i) the inaccuracy of any representation or
warranty of Seller which is contained in or made pursuant to this Agreement; or
(ii) any material breach by Seller of any of Seller’s agreements or obligations
contained in or made pursuant to this Agreement.

    

    
      
        2

      

      
        
          

        

      

      
         

      

    

    (c)           Limitation of
Liability.  The total aggregate liability of each party hereto
shall be limited to the Purchase Amount.

    

    4.           Releases. As material
consideration for the transactions set forth in this Agreement,

    

               (a)           Release by the
Company.  The Company, on behalf of itself and its unitholders,
predecessors, subsidiaries, related entities, successors in interest, assigns,
directors, officers, employees, agents, representatives, attorneys, contractors,
subcontractors, independent contractors, owners and partners (collectively, its
“Affiliates”), hereby releases, remises and forever discharges Seller and
Seller’s Affiliates from any and all claims, contracts, demands, causes of
action, disputes, obligations, agreements, covenants, damages, costs, and expenses
(collectively, “Claims”), known or unknown, of any kind, nature, or description,
which the Company has, may have had, or may hereafter assert which have accrued
up to the date of this Agreement.

    

               (b)           Release by
Seller.  Seller, on behalf of itself and its Affiliates, hereby
releases, remises and forever discharges the Company and its Affiliates, from
any and all Claims, known or unknown, of any kind, nature, or description, which
Seller has, may have had or may hereafter assert which have accrued up to the
date of this Agreement.

    

    (c)           Scope of
Releases.  The parties acknowledge and agree that each of the
foregoing releases in this Article 4 is intended to be a general
release with
respect to all matters which have accrued up to the date of this
Agreement.  Notwithstanding the general nature of such releases, the
parties acknowledge and agree that nothing in this Article 4 shall operate to
prevent a party from asserting claims or enforcing rights that arise under this
Agreement including, without limitation, actions based upon the material
inaccuracy of any representation or warranty of a party in this Agreement,
actions based upon the material breach by a party of covenants or obligations
set forth herein, and actions seeking equitable relief to enforce this
Agreement.

    

    5.           Confidentiality
and Related Matters.

    

               (a)           Confidentiality.  The
parties agree not to disclose the fact or substance of this Agreement,
including, but not limited to, the existence or any terms of this Agreement, and
the amount of the payments made pursuant hereto.  The parties further
agree not to use or disclose any confidential information belonging to the other
party.  The foregoing confidentiality obligations shall not restrict
the following disclosures:  (i) disclosures that may be necessary to
enforce the terms and conditions of this Agreement; (ii) disclosures that may be
necessary by the respective parties to discuss with their attorneys, accountants
or corporate employees on a “need to know” basis; (iii) disclosures pursuant to
a subpoena or specific court or agency order; and (iv) disclosures necessary to
comply with the Securities Act of 1933, as amended, the Securities Exchange Act
of 1934, as amended, the Internal Revenue Code, state tax law or any other
applicable law and (v) Seller’s communications with its shareholders concerning
the transaction contemplated hereby and which may become a matter of public
record.  The Company intends to make public disclosure of this
Agreement and/or its terms by filing a Current Report on Form 8-K with the
Securities and Exchange Commission and subsequent periodic reports.

    

    (b)           Non-Disparagement,
Etc.  Each party agrees that it will not make, or cause any
other person or entity to make, any adverse, derogatory, or disparaging remarks,
statements, or communications about the other party or any of its
Affiliates.

    

    
      
        3

      

      
        
          

        

      

      
         

      

    

    6.           General
Provisions.

    

    (a)           Cooperation.  Each
party agrees that it will (and will cause any respective Affiliates to)
cooperate fully with the other party to endeavor to bring to full fruition the
objectives of this Agreement, and at all times regarding the transactions
contemplated by this Agreement act in good faith and take such actions as may be
necessary or convenient to effect fully the provisions of this Agreement,
including, without limitation, the execution and delivery of such further
instruments or documents as may be necessary or convenient to carry out the
transactions contemplated hereby.

    

    (b)           Severability.  To
the extent that any provision of this Agreement may be held to be invalid or
legally unenforceable by a court of competent jurisdiction, the parties agree
that
 the remaining provisions of this
Agreement shall not be affected and shall be given full force and
effect.

    

    (c)           No
Waiver.  No waiver of any provision hereof or of any right or
remedy hereunder shall be effective unless in writing and signed by the party
against whom such waiver is sought to be enforced.  No failure or
delay of a party in exercising any right hereunder shall operate as a waiver
thereof, nor shall any single or partial exercise of any such right preclude any
other or further exercise thereof or the exercise of any other
right.

    

    (d)           Miscellaneous.  This
Agreement shall be governed by the internal laws of the State of Delaware,
without regard to its conflict of laws principles.  This Agreement
sets forth the entire agreement and understanding of the parties with respect to
this engagement, and supersedes all prior agreements, whether written or oral,
regarding the matters described herein, and may only be amended in writing by
duly authorized employees of each party.  This Agreement may not be
assigned or delegated by either party without the express written consent of the
other party.  The benefits of, and obligations and liabilities under
this Agreement shall inure to, and be binding upon, the respective successors
and permitted assigns (whether by merger, acquisition, or otherwise) of the
parties and of any persons entitled to indemnification pursuant to Article 3
hereof.  This Agreement may be executed via facsimile and in
counterparts, each of which shall be deemed an original and all of which taken
together shall constitute one and the same instrument.

    

    IN
WITNESS WHEREOF, the parties have executed this Unit Purchase and Mutual Release
Agreement as of the date first set forth above.

    

    

     

    
      	 SELLER	 	 THE
      COMPANY
	 	 	 	 	 
	 ST.
      LAWRENCE SEAWAY CORPORATION	 	 T3
      THERAPEUTICS, LLC
	 	 	 	 	 
	 By:	/s/ Bernard
      Zimmerman	 	 By:	/s/ Irwin Klein
	 	
              Bernard
      Zimmerman

              President
      and Chief Executive

              Officer

            	 	 	
              Irwin
      Klein

              Chief
      Executive Officer

            
	 	 	 	 	 

    

     

     

     

     

    

    
      
        4 

      

      
        
          

        

      

      
         

      

    

    EXHIBIT
A

    

    St. Lawrence Seaway
Corporation

    (a
Delaware corporation)

    

    Bill
of Sale/Officer Certificate

    

    January
21, 2010

    

    The undersigned representative of St.
Lawrence Seaway Corporation., a Delaware corporation (“Seller”),
hereby certifies and confirms the following to T3 Therapeutics, LLC, a Delaware
limited liability company (the “Company”)
in connection with that certain Unit Purchase and Mutual Release Agreement
between the parties of even date herewith (the “Purchase
Agreement”).

    

    1.    The
undersigned individual is a duly authorized officer of the Seller with all
necessary power and authority to sign this Bill of Sale/Officer Certificate on
behalf of Seller and to make the representations and conveyances set forth
herein.

    

    2.    Seller is
the holder of record of 250 uncertificated units of membership interest in the
Company (the “Seller
Units”) and is a signatory to the Company’s Amended and Restated
Operating Agreement dated November 16, 2005, as amended from time to
time.

    

    3.    Seller
hereby irrevocably sells, conveys, transfers, and assigns to the Company all of
its right, title, and interest in and to the Seller Units in exchange for the
consideration set forth in the Purchase Agreement and pursuant to the terms
thereof.

    

    IN
WITNESS WHEREOF, the undersigned has duly executed this Bill of Sale/Officer
Certificate as of the date first above written.

    

     
 

    

    

    
       

      
        	 	 	 
	 	/s/ Bernard Zimmerman	 
	  	
                President
      and Chief Executive Officer,

                For
      St. Lawrence Seaway Corporation

              	 
	 	 	 

      

       

                                                                                    

    

                           

                               

     

    5QuickLinks
 -- Click here to rapidly navigate through this document

 

 
 

  Exhibit 4.3    
    

   

  

  

  

  

  

  

  

  

 
 

  CONVIO, INC.    
    
    FIFTH AMENDED AND RESTATED    
    
    INVESTORS' RIGHTS AGREEMENT    
    
    April 10, 2007    
    

  

  

  

   

   

   

   

   

   

 
 

TABLE OF CONTENTS    
    

 

 

							
	 
	 	 
	 	Page 	 
	1.	 	 Certain Definitions	 	 	 1	 
	
2.	
 	
 Restrictions on Transferability	
 	
 	
 2	
 
	
3.	
 	
 Restrictive Legend	
 	
 	
 2	
 
	
4.	
 	
 Notice of Proposed Transfers.	
 	
 	
 3	
 
	
5.	
 	
 Requested Registration.	
 	
 	
 3	
 
	
6.	
 	
 Company Registration.	
 	
 	
 5	
 
	
7.	
 	
 Expenses of Registration	
 	
 	
 6	
 
	
8.	
 	
 Registration Procedures	
 	
 	
 6	
 
	
9.	
 	
 Registration on Form S-3	
 	
 	
 7	
 
	
10.	
 	
 Termination of Registration Rights	
 	
 	
 8	
 
	
11.	
 	
 Lock-up Agreement	
 	
 	
 8	
 
	
12.	
 	
 Indemnification.	
 	
 	
 8	
 
	
13.	
 	
 Information by Holder	
 	
 	
 10	
 
	
14.	
 	
 Rule 144 Reporting	
 	
 	
 10	
 
	
15.	
 	
 Transfer of Registration Rights	
 	
 	
 10	
 
	
16.	
 	
 Subsequent Grant of Registration Rights	
 	
 	
 10	
 
	
17.	
 	
 Information.	
 	
 	
 10	
 
	
18.	
 	
 Visitation Rights	
 	
 	
 12	
 
	
19.	
 	
 Termination of Information and Visitation Rights	
 	
 	
 12	
 
	
20.	
 	
 Rights of First Offer	
 	
 	
 12	
 
	
21.	
 	
 Covenants	
 	
 	
 13	
 
	
22.	
 	
 Election of Directors.	
 	
 	
 16	
 
	
23.	
 	
 Board Observer Rights	
 	
 	
 18	
 
	
24.	
 	
 Non-Disclosure of Investment Interests	
 	
 	
 18	
 
	
25.	
 	
 Governing Law	
 	
 	
 18	
 
	
26.	
 	
 Entire Agreement	
 	
 	
 18	
 
	
27.	
 	
 Notices, Etc	
 	
 	
 18	
 
	
28.	
 	
 Counterparts; Facsimile Signatures	
 	
 	
 18	
 
	
29.	
 	
 Amendment	
 	
 	
 18	
 
	
30.	
 	
 Independent Counsel	
 	
 	
 19	
 

 

 

 

					
	
 Schedule I	
 	
 —	
 	
 Schedule of Preferred Stockholders
	Schedule II	 	 —	 	 Schedule of Common Stockholders

 

 

 

 
 

  CONVIO, INC.    
    
    FIFTH AMENDED AND RESTATED
  INVESTORS' RIGHTS AGREEMENT    
    

        This Fifth Amended and Restated Investors' Rights Agreement (this "Agreement") is
entered into as of April 10, 2007 by and among Convio, Inc., a Delaware corporation (the "Company"), each of those holders of the
Company's Series P Common Stock, Series Q Common Stock, Series R Common Stock, Series S Common Stock, each with a par value $0.001 per share (collectively, the
"Common Stock"), identified on Schedule I hereto (individually, a "Common
Holder," and collectively, the "Common Holders"), each of the holders of the Company's Series A Convertible Preferred
Stock, Series B Convertible Preferred Stock and Series C Preferred Stock, each with a par value of $0.001 per share, or shares of the Company's capital stock issuable upon conversion
thereof (collectively, the "Preferred Stock"), listed on Schedule II hereto (individually, a
"Preferred Holder" and collectively, the "Preferred Holders"). This Agreement amends, supersedes and
replaces the Company's Fourth Amended and Restated Investors' Rights Agreement, dated as of February 16, 2007 (the "Prior Agreement"). 

 
 

RECITALS    

        A.    The
founders of the Company ("Founders"), holders of the Company's Series A Convertible Preferred Stock
("Series A Stock") and the holders of the Company's Series B Convertible Preferred Stock ("Series B
Stock") and certain key employees of the Company ("Key Employees") (collectively, the "Prior
Investors") possess registration rights, rights of first offer and other rights granted in the Prior Agreement; 

        B.    Section 28
of the Prior Agreement allows amendment of its terms upon the written consent of the Company and of the holders of at least two-thirds of
the Series A Preferred Stock and Series B Preferred Stock, voting together; 

        C.    The
Company and certain investors are parties to that certain Series C Preferred Stock Purchase Agreement of even date herewith, which provides, among other
things, for the issuance by the Company of shares of the Company's Series C Convertible Preferred Stock. 

        D.    The
parties hereto desire to amend and restate the Prior Agreement and to accept the rights created pursuant hereto in lieu of the rights granted under the Prior
Agreement. 

 
 

AGREEMENT    

        1.    Certain Definitions.    As used in this Agreement, the following terms shall have the following respective
meanings: 

        "Commission" shall mean the Securities and Exchange Commission or any successor agency. 

        "Holder" shall mean each Preferred Holder and each Common Holder and any transferee of Registrable Securities from a Preferred Holder or
Common Holder who, pursuant to Section 15 below, is entitled to registration rights hereunder. 

        "New Securities" shall have the meaning set forth in Section 20(a) of this
Agreement. 

        "Registrable Securities" shall mean (i) shares of the Company's Common Stock issued or issuable upon the conversion of the
Preferred Stock; (ii) any other securities issued or issuable in respect of shares of the Preferred Stock; (iii) shares of the Company's Common Stock held by Common Holders, and
(iv) shares of the Company's Common Stock or other securities issued or issuable in respect of the shares described in clauses (i)-(iii) upon any stock split, stock dividend,
recapitalization, or similar event; provided, however, that any shares described in
clauses (i)-(iv) above
which have been resold to the public following a registered public offering shall cease to be Registrable Securities upon such resale. 

 

        The
terms "register," "registered" and
"registration" refer to a registration effected by preparing and filing a registration statement in compliance with the Securities Act and the
declaration or ordering of the effectiveness of such registration statement. 

        "Registration Expenses" shall mean all expenses (excluding underwriter discounts and expenses) incurred by the Company in complying with  Sections 5, 6, 8 and
9 hereof, including, without limitation, all registration, qualification and
filing fees, printing expenses, escrow fees, fees and disbursements of counsel for the Company, blue sky fees and expenses and the expense of any special audits incident to or required by any such
registration but exclusive of Selling Expenses; and the fees and expenses of one (1) counsel to selling Holders of up to $25,000. 

        "Restricted Securities" shall mean the securities of the Company required to bear the legend set forth in  Section 3 hereof (or any similar legend).

        "Securities Act" shall mean the Securities Act of 1933, as amended. 

        "Selling Expenses" shall mean all underwriting discounts, selling commissions and stock transfer taxes applicable to the securities
registered by the Holders. 

        "Shares" shall mean any shares of the Company's capital stock now held or hereafter acquired by any party hereto. 

        2.    Restrictions on Transferability.    The Restricted Securities shall not be transferable except upon the
conditions specified in this Agreement, which conditions are intended to ensure compliance with the provisions of the Securities Act. Each Holder of Restricted Securities will cause any proposed
transferee of the Restricted Securities held by such Holder, other than a transferee acquiring such securities in connection with a registered offering covering such disposition, to agree to take and
hold such Restricted Securities subject to the provisions and upon the conditions specified in this Agreement. 

        3.    Restrictive Legend.    Each certificate representing (i) the Preferred Stock, (ii) shares of the
Company's Common Stock issued upon conversion of the Preferred Stock, (iii) any other securities issued in respect of the Preferred Stock or Common Stock issued upon conversion of the Preferred
Stock including upon any stock split, stock dividend, recapitalization, merger, consolidation or similar event, shall (unless otherwise permitted by the provisions of  Section 4 below) be stamped or
otherwise imprinted with a legend in substantially the following form (in addition to any legend required under
applicable securities laws): 

THE
SHARES REPRESENTED BY THIS CERTIFICATE HAVE BEEN ACQUIRED FOR INVESTMENT AND HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR ANY APPLICABLE STATE SECURITIES LAWS. THESE SHARES MAY NOT
BE SOLD OR TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN EXEMPTION THEREFROM UNDER SAID ACTS AND REGISTRATION OR QUALIFICATION UNDER APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL
SATISFACTORY TO THE CORPORATION THAT SUCH REGISTRATION OR QUALIFICATION IS NOT REQUIRED. COPIES OF THE AGREEMENT RESTRICTING THE TRANSFER OF THESE SHARES MAY BE OBTAINED AT NO COST BY WRITTEN REQUEST
MADE BY THE HOLDER OF RECORD OF THIS CERTIFICATE TO THE SECRETARY OF THE CORPORATION AT THE PRINCIPAL EXECUTIVE OFFICES OF THE CORPORATION. 

        Each
Holder consents to the Company's making a notation on its records and giving instructions to any transfer agent for the Company in order to implement the restrictions on transfer
established in this Section 3. The Company shall be obligated to reissue promptly unlegended certificates at the request of any Holder thereof if
the Holder shall have obtained an opinion of counsel at such Holder's 

2

 

expense
(which counsel may be counsel to the Company) reasonably acceptable to the Company to the effect that the securities proposed to be disposed of may lawfully be so disposed of without
registration, qualification or legend. 

        4.    Notice of Proposed Transfers.    The Holder of each certificate representing Restricted Securities by acceptance
thereof agrees to comply in all respects with the provisions of this Section 4. Prior to any proposed transfer of any Restricted Securities,
unless there is in effect a registration statement under the Securities Act covering the proposed transfer, the Holder thereof shall give written notice to the Company of such Holder's intention to
effect such transfer. Each such notice shall describe the manner and circumstances of the proposed transfer in sufficient detail, and shall, if the Company reasonably requests, be accompanied (except
in transactions in compliance with Rule 144) by either (i) a written opinion of legal counsel who shall be reasonably satisfactory to the Company, addressed to the
Company and reasonably satisfactory in form and substance to the Company's counsel, to the effect that the proposed transfer of the Restricted Securities may be effected without registration under the
Securities Act, or (ii) a "No Action" letter from the Commission to the effect that the transfer of such securities without registration will not result in a recommendation by the staff of the
Commission that action be taken with respect thereto, whereupon the Holder of such Restricted Securities shall be entitled to transfer such Restricted Securities in accordance with the terms of the
notice delivered by the Holder to the Company; provided, however, that no opinion or "No Action" letter
need be obtained with respect to a transfer, if the transferee agrees to be subject to the terms hereof, to (A) if a Holder of Restricted Securities is a partnership, a partner, whether active
or retired, of such Holder of Restricted Securities, (B) the estate of any Holder of Restricted Securities, (C) an "affiliate" of a Holder of Restricted Securities as that term is
defined in Rule 405 promulgated by the Commission under the Securities act, (D) if the Holder is a corporation, to its stockholders, (E) if the Holder is a limited liability
company, to its members or former members, or (F) the spouse, children, grandchildren or spouse of such children or grandchildren of any Holder or to trusts for the benefit of any Holder or
such persons. Each certificate evidencing the Restricted Securities transferred as above provided shall bear the restrictive legend in substantially the form set forth in  Section 3 above, except
that such certificate shall not bear such restrictive legend if the transferee provides an opinion of counsel as provided
in Section 3 or in the opinion of counsel for the Company such legend is not required in order to establish compliance with any provisions of the
Securities Act or applicable state securities laws. 

        5.    Requested Registration.    

        (a)    Request for Registration.    If at any time after the earlier of (i) three (3) years after the
date of this Agreement, or (ii) one hundred eighty (180) days following the closing date of the first registration statement filed by the Company covering an underwritten offering of any
of its securities to the general public, the Company shall receive from any Holder or group of Holders holding at least sixty-six and two-thirds percent (662/3%)
in interest of the Registrable Securities (the "Initiating Holders") a written request that the Company effect any registration with respect to
Registrable Securities having an aggregate offering price of not less than $5,000,000, the Company will: 

        (i)    promptly
give written notice of the proposed registration, qualification or compliance to all other Holders; and 

        (ii)   as
soon as practicable, use its reasonable best efforts to effect such registration (including, without limitation, filing post-effective amendments,
appropriate qualification under applicable blue sky or other state securities laws and appropriate compliance with applicable regulations issued under the Securities Act and any other governmental
requirements or regulations) as would permit or facilitate the sale and distribution of all or such portion of such Registrable Securities as are specified in such request, together with all or such
portion 

3

 

of
the Registrable Securities of any Holder or Holders joining in such request as are specified in a written request received by the Company within twenty (20) days after receipt of such
written notice from the Company, subject to the terms and conditions of this Section 5; 

        Provided, however, that the Company shall not be obligated to take any action to effect
any such registration pursuant to this Section 5: 

        (A)  In
any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting such registration, qualification or
compliance unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

        (B)  After
the Company has effected two (2) such registrations pursuant to this Section 5(a), which
registrations have been declared or ordered effective, and pursuant to which the securities offered have been sold; 

        (C)  During
the one hundred eighty (180) day period starting with the date sixty (60) days prior to the Company's estimated date of filing of, and ending on the
date immediately following the effective date of any Company-initiated registration statement pertaining to securities of the Company (other than a registration of securities in a Rule 145
transaction or with respect to an employee benefit plan); or 

        (D)  If
the Company delivers notice to the Holders of Registrable Securities within thirty (30) days of any such request for registration of the Company's intent to file a
registration statement for its initial public offering within ninety (90) days from the date of such registration request. 

        Subject
to the foregoing clauses (A), (B), (C) and (D), the Company shall file a registration statement covering the Registrable Securities so requested to be registered as soon
as practicable after receipt of the request or requests of the Initiating Holders. If, however, the Company shall furnish to the Initiating Holders a certificate signed by the President of the Company
stating that, in the good faith judgment of the Board of Directors of the Company, it would be seriously detrimental to the Company and its stockholders for such registration statement to be filed and
it is therefore essential to defer the filing of such registration statement, the Company shall have the right to defer such filing for a period
of not more than ninety (90) days after receipt of the request of the Initiating Holders, provided,  however, that the Company may not utilize this
right more than once in any twelve-month period. 

        (b)    Underwriting.    If the Initiating Holders intend to distribute the Registrable Securities covered by their
request by means of an underwriting, they shall so advise the Company as a part of their request made pursuant to Section 5(a) and the Company
shall include such information in the written notice referred to in Section 5(a). The right of any Holder to registration pursuant to  Section 5
shall be conditioned upon such Holder's participation in such underwriting and the inclusion of such Holder's Registrable Securities to
be registered in the underwriting to the extent requested (unless otherwise mutually agreed by a majority in interest of the Holders) and to the extent provided herein. A Holder may elect to include
in such underwriting all or a part of the Registrable Securities such Holder holds. 

        The
Company shall (together with all Holders proposing to distribute their securities through such underwriting) enter into an underwriting agreement in customary form with the managing
underwriter mutually agreed upon for such underwriting by the Company and a majority in interest of the Initiating Holders. Notwithstanding any other provision of this  Section 5, if the managing
underwriter advises the Initiating Holders in writing that marketing factors require a limitation of the number of
shares to be underwritten, then, subject to the provisions of Section 5(a), the Company shall so advise all Holders and the number of shares that
may be included in the registration and underwriting shall be allocated 

4

 

among
all persons or entities requesting inclusion in the registration as follows: (A) all securities proposed to be offered by the Company for its own account or for the account of holders of
securities other than Registrable Securities shall be excluded before any Registrable Securities are excluded; and (B) if, after all non-Registrable Securities have been excluded,
additional limitations are required, then the number of Registrable Securities included in the registration shall be allocated among all Holders requesting inclusion thereof in the registration in
proportion, as nearly as practicable, to the respective amounts of Registrable Securities held by such Holder. 

        If
any Holder of Registrable Securities disapproves of the terms of the underwriting, such person may elect to withdraw therefrom by written notice to the Company, the managing
underwriter and the other Holders. The Registrable Securities and/or other securities so withdrawn shall also be withdrawn from registration; provided,  however, that if by the withdrawal of such Registrable Securities a greater number of Registrable Securities held by other Holders may be included in
such registration (up to the maximum of any limitation imposed by the underwriters), then the Company shall offer to all Holders who have included Registrable Securities in the registration the right
to include additional Registrable Securities in the same proportion used in determining the underwriter limitation in this Section 5(b). If the
registration does not become effective due to the withdrawal of Registrable Securities at the behest of the Holder(s) of such Registrable Securities and the withdrawal of the registration is not at
the request or on the advice of the Company or the underwriter nor is the result of a material adverse change in the Company's business, financial condition, results of operations or prospects since
the date of the written request of the Initiating Holders pursuant to this Section 5, then either (1) the Holders requesting registration
shall reimburse the Company for expenses incurred in complying with the request or (2) the aborted registration shall be treated as effected for purposes of  Section 5(a)(B). 

        6.    Company Registration.    

        (a)    Notice of Registration.    If the Company proposes to register under the Securities Act any of its securities
for sale by a security holder (other than (i) pursuant to a registration in connection with an employee benefit or stock ownership plan, (ii) pursuant to  Sections 5 or 9, or (iii) a registration relating solely to a Rule 145 transaction)
and the registration form to be used may be used for the registration of Registrable Securities, the Company will give prompt written notice to all Holders of its intention to effect such a
registration (each, a "Piggyback Notice"). Subject to Section 6(b) below, the Company will
include in such registration all shares of Registrable Securities which holders of Registrable Securities request the Company to include in such registration by written notice given to the Company
within twenty (20) days after receipt of the above-described notice from the Company. 

        (b)    Priority on Company Registrations.    If a registration subject to  Section 6(a) relates to an underwritten public
offering of equity securities by holders of the Company's securities and the managing underwriters
advise the Company in writing that in their opinion the number of securities requested to be included in such registration exceeds the number which can be sold in an orderly manner in such offering
within a price range acceptable to the Holders initially requesting such registration, the Company will include in such registration (i) first, the securities requested to be included therein
by the Company if the Company has initiated the registration; (ii) second, the Registrable Securities requested to be included in such registration by the Holders, allocated pro rata among the
Holders thereof on the basis of the number of shares of Registrable Securities held by such Holders; and (iii) third, among persons not contractually entitled to registration rights under this
Agreement; provided, however, that in no event shall the amount of securities of the Holders included in the offering be reduced below twenty-five percent (25%) of the total amount of the
securities included in such offering unless such offering is the Company's initial public offering, in which case all securities of the Holders may be excluded (so long as no securities are included
in such offering other than shares offered by the Company). 

5

 

        (c)   The
Company may, in its sole discretion, abandon or delay any registration initiated by the Company pursuant to this  Section 6. 

        7.    Expenses of Registration.    All Registration Expenses incurred in connection with any registration,
qualification or compliance pursuant to Sections 5, 6 and 9 shall be borne by the Company;  provided,
however, if a registration proceeding is begun upon the request of the Holders pursuant to  Sections 5 or 9, but such request is subsequently withdrawn at the request of the Holders, then
the Holders of the Registrable Securities to have been registered may either: (i) bear all Registration Expenses of such proceeding, pro rata on the basis of the number of shares to have been
registered, in which case the
Company shall be deemed not to have effected a registration pursuant to Sections 5 or 9 of this
Agreement, as applicable; or (ii) require the Company to bear all Registration Expenses of such proceeding, in which case the Company shall be deemed to have effected a registration pursuant to  Sections 5 or 9 of this Agreement, as applicable. Nevertheless, if subsequent to such request for
registration and prior to the request of such withdrawal, the Holders have learned of a material adverse change in the condition, business, or prospects of the Company from the condition, business or
prospects of the Company known to the Holders at the time of their request and have withdrawn the request with reasonable promptness following disclosure by the Company of such material adverse
change, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Section 5, 6 or  9, as applicable.
All Selling Expenses relating to securities registered by the Holders shall be borne by the Holders of such securities pro rata on the
basis of the number of shares so registered. 

        8.    Registration Procedures.    In the case of each registration, qualification or compliance effected by the
Company pursuant to this Agreement the Company will keep each Holder advised in writing as to the initiation of each registration, qualification and compliance and as to the completion thereof. At its
expense the Company will: 

        (a)   Prepare
and file with the Commission a registration statement with respect to such securities and use its best efforts to cause such registration statement to become and
remain effective for at least one hundred twenty (120) days or until the distribution described in the registration statement has been completed;  provided, however, that (i) such 120-day period shall be extended for a period of
time equal to the period the Holder refrains from selling any securities included in such registration at the request of an underwriter of securities of the Company; and (ii) in the case of any
registration of Registrable Securities on Form S-3 which are intended to be offered on a continuous or delayed basis, such 120-day period shall be extended, if
necessary, to keep the registration statement effective until all such Registrable Securities are sold; 

        (b)   Furnish
to the Holders participating in such registration and to the underwriters of the securities being registered such number of copies of the registration statement,
preliminary prospectus, final prospectus and such other documents as such Holders or underwriters may reasonably request in order to facilitate the public offering of such securities; 

        (c)   Prepare
and file with the Commission such amendments and supplements to such registration statement and the prospectus used in connection with such registration
statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement or to applicable
anti-fraud provisions; 

        (d)   Use
its best efforts to register and qualify the securities covered by such registration statement under such other applicable securities or blue sky laws,  provided that the Company shall not be required in
connection therewith or as a condition thereto to qualify to do business or to file a general consent
to service of process in any such states or jurisdictions unless the Company is already subject to service in such jurisdiction and except as may be required by the Securities Act; 

6

 

        (e)   Cause
all such Registrable Securities registered pursuant hereto to be listed on each securities exchange on which similar securities issued by the Company are then
listed; 

        (f)    Provide
a transfer agent and registrar for all Registrable Securities registered pursuant to such registration statement and a CUSIP number for all such Registrable
Securities, in each case not later than the effective date of such registration; 

        (g)   Enter
into an underwriting agreement in form reasonably necessary to effect the offer and sale of Registrable Securities; 

        (h)   Notify
each Holder of Registrable Securities covered by such registration statement at any time when a prospectus relating thereto is required to be delivered under the
Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or omits to
state a material fact required to be stated therein or necessary to make the statements therein not misleading in the light of circumstances then existing; and 

        (i)    Furnish,
at the request of any Holder requesting registration of Registrable Securities, on the date that such Registrable Securities are delivered to the underwriters
for sale, if such securities are being sold through underwriters, or, if such securities are not being sold through underwriters, on the date that the registration statement with respect to such
securities becomes effective, (i) an opinion, dated as of such date, of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given
to underwriters in an underwritten public offering and reasonably satisfactory to a majority in interest of the Holders requesting registration, addressed to the underwriters, if any, and to the
Holders requesting registration of Registrable Securities and (ii) a "comfort" letter dated as of such date, from the independent certified public accountants of the Company, in form and
substance as is customarily given by independent certified public accountants to underwriters in an underwritten public offering and reasonably satisfactory to a majority in interest of the Holders
requesting registration, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities. 

        9.    Registration on Form S-3.    In addition to the rights set forth above, if any Holder
requests in writing that the Company file a registration statement on Form S-3 (or any successors thereto) with aggregate proceeds of at least $500,000 (a
"Follow-On Registration") for a public offering of shares of Registrable Securities and the Company is entitled to use
Form S-3 to register securities for such an offering, the Company shall use its best
efforts to effect such registration (including, without limitation, filing post-effective amendments, appropriate qualifications under applicable blue sky or other state securities laws,
and appropriate compliance with the Securities Act). The Company will promptly give written notice of the request for the proposed registration to all other Holders and include all Registrable
Securities of any Holder or Holders joining in such request as are specified in a written request received by the Company within thirty (30) days after receipt of such written notice from the
Company. The written request of a Holder may specify that all or part of such Holder's Registrable Securities will be included in such registration. If the Follow-On Registration is for an
underwritten offering, the provisions of Section 5(b) shall apply to such registration. Notwithstanding the foregoing, the Company shall not be
obligated to effect any such registration, qualification or compliance, pursuant to this Section 9: 

        (a)   if
the Company shall furnish to the Holders initiating the registration on Form S-3 a certificate signed by the President of the Company stating that,
in the good faith judgment of the Board of Directors of the Company, it would be seriously detrimental to the Company and its stockholders for such Form S-3 registration statement
to be filed and it is therefore essential to defer such filing; in which event the Company shall have the right to defer such filing for a period of not more than ninety (90) days after receipt
of the request of the Holders initiating the 

7

 

registration
on Form S-3 under this Section 9, provided,  however, that the Company may not utilize this right
more than once in any twelve-month period; or 

        (b)   if
the Company has, within any 90-day period already effected one (1) registration or within the twelve (12) month period preceding the date of
such request already effected two (2) registrations on Form S-3 for Holders pursuant to this Section 9; 

        (c)   if
the Company has effected two (2) such registrations pursuant to this Section 9; or 

        (d)   in
any particular jurisdiction in which the Company would be required to qualify to do business or to execute a general consent to service of process in effecting such
registration, qualification or compliance unless the Company is already subject to such service in such jurisdiction and except as may be required by the Securities Act. 

        10.    Termination of Registration Rights.    The registration rights granted pursuant to this Agreement shall
terminate as to any Holder, at such time after the Company's initial public offering that all Registrable Securities held by such Holder can be sold in a single three-month period pursuant to
Rule 144 promulgated under the Securities Act. 

        11.    Lock-up Agreement.    In consideration for the Company agreeing to its obligations under this
Agreement, each Holder of Registrable Securities and each transferee pursuant to Section 15 hereof agrees, in connection with the first
registration of the Company's securities, that such holder shall not, without the prior consent of the Company or the underwriters managing any underwritten offering of the Company's securities, sell,
make any short sale of, loan, grant any option for the purchase of, or otherwise dispose of any Registrable Securities (other than those included in the registration), as the case may be, for a period
of up to one hundred eighty (180) days from the effective date of such registration; provided,  however that all officers, directors and holders of one
percent (1%) or more of the outstanding capital stock of the Company enter into similar
lock-up agreements as well. Each Holder agrees that the Company may instruct its transfer agent to place stop transfer notations in its records to enforce the provisions of this  Section 11.

        12.    Indemnification.    

        (a)   The
Company will indemnify each Holder, each of its officers, directors and partners, legal counsel, accountants, underwriters and each person controlling such Holder
within the meaning of Section 15 of the Securities Act, with respect to which registration, qualification or compliance has been effected pursuant to this Agreement, and each underwriter, if
any, and each person who controls any underwriter within the meaning of Section 15 of the Securities Act, against all expenses, claims, losses, damages and liabilities (or actions in respect
thereof), including any of the foregoing incurred in settlement of any litigation, arising out of or based on (i) any untrue statement (or alleged untrue statement) of a material fact contained
in any registration statement, prospectus, offering circular or other document, or any amendment or supplement thereto, incident to any such registration, qualification or compliance, or
(ii) any omission (or alleged omission) to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, or (iii) any violation
or alleged violation by the Company of the Securities Act, the Securities Exchange Act of 1934, as amended (the "Exchange Act"), any federal or state
securities law, or any rule or regulation promulgated thereunder applicable to the Company and relating to action or inaction required of the Company in connection with any such registration,
qualification or compliance, and will reimburse each such Holder, each of its officers, directors and partners and each person controlling such Holder, each such underwriter and each person who
controls any such underwriter, for any legal and any other expenses reasonably incurred in connection with investigating, preparing or defending any such claim, loss, damage, liability or action,  provided, however, that the indemnity agreement contained in this  Section 12(a) shall not apply to amounts paid in settlement of any such loss, claim,
damage, liability or action if such settlement is effected
without the consent of the Company (which consent 

8

 

shall
not be unreasonably withheld), nor shall the Company be liable in any such case for any such loss, claim, damage, liability or action to the extent that it arises out of or is based upon any
untrue statement or omission or alleged untrue statement or omission, that occurs in reliance upon and in conformity with written information furnished expressly for use in connection with such
registration by any such Holder or underwriter and stated to be specifically for use therein. 

        (b)   Each
Holder will, if Registrable Securities held by such Holder are included in the securities as to which such registration, qualification or compliance is being
effected, indemnify the Company, each of
its directors and officers, legal counsel, accountants each underwriter, if any, of the Company's securities covered by such a registration statement, each person who controls the Company or such
underwriter within the meaning of Section 15 of the Securities Act, and each other such Holder, each of its officers and directors and each person controlling such Holder within the meaning of
Section 15 of the Securities Act, against all expenses, claims, losses, damages and liabilities (or actions in respect thereof) arising out of or based on (i) any untrue statement (or
alleged untrue statement) of a material fact contained in any such registration statement, prospectus, offering circular or other document, or (ii) any omission (or alleged omission) to state
therein a material fact required to be stated therein or necessary to make the statements therein not misleading, and will reimburse the Company, such Holders, such directors, officers, legal counsel,
accountants, underwriters or control persons for any legal or any other expenses reasonably incurred in connection with investigating or defending any such claim, loss, damage, liability or action, in
each case to the extent, but only to the extent, that such untrue statement (or alleged untrue statement) or omission (or alleged omission) is made in such registration statement, prospectus, offering
circular or other document in reliance upon and in conformity with written information furnished to the Company by an instrument duly executed by such Holder and stated to be specifically for use
therein; provided, however, that the obligations of such Holder hereunder shall not apply to amounts
paid in settlement of any such claims, losses, damages or liabilities (or actions in respect thereof) if such settlement is effected without the consent of such Holder and  provided that the obligations
of each such Holder hereunder shall be limited to an amount equal to the net proceeds after expenses and commissions to
such Holder from Registrable Securities sold in such offering. 

        (c)   Each
party entitled to indemnification under this Section 12 (the "Indemnified
Party") shall give notice to the party required to provide indemnification (the "Indemnifying Party") promptly after such
Indemnified Party has actual knowledge of any claim as to which indemnity may be sought, and shall permit the Indemnifying Party to assume the defense of any such claim or any litigation resulting
therefrom, provided that counsel for the Indemnifying Party, who shall conduct the defense of such claim or litigation, shall be approved by the
Indemnified Party (whose approval shall not be unreasonably withheld), and the Indemnified Party may participate in such defense at such party's expense; and provided
further that the failure of any Indemnified Party to give notice as provided herein shall not relieve the Indemnifying Party of its obligations under this Agreement, except to
the extent, but only to the extent, that the Indemnifying Party's ability to defend against such claim or litigation is impaired as a result of such failure to give notice. No Indemnifying Party, in
the defense of any such claim or litigation, shall, except with the consent of each Indemnified Party, consent to entry of any judgment or enter into any settlement which does not include as an
unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party of a release from all liability in respect to such claim or litigation. 

        (d)   If
the indemnification provided for herein is held by a court of competent jurisdiction to be unavailable to an indemnified party with respect to any loss, claim,
damage, liability or expense referred to herein, then the indemnifying party, in lieu of indemnifying such indemnified party hereunder, shall contribute to the amount paid or payable by such
indemnified party as a result of such loss, claim, damage, liability or expense in such proportion as is appropriate to reflect the relative fault of the indemnifying party, on the one hand, and of
the indemnified party, on the other, in connection with the action or omission that resulted in such loss, claim, damage, liability or expense, as well as any other relevant equitable considerations.
The obligation of Holders to contribute will be individual to each Holder and will be limited to the net amount of proceeds received by such Holder from the sale of Registrable Securities. 

9

 

  
        13.    Information by Holder.    The Holder(s) of Registrable Securities included in any registration shall furnish
to
the Company such information regarding such Holder or Holders and the distribution proposed by such Holder or Holders as the Company may request in writing and as shall be reasonably required in
connection with any registration, qualification or compliance referred to in this Agreement. 

        14.    Rule 144 Reporting.    With a view to making available the benefits of certain rules and regulations of
the Commission which may at any time permit the sale of the Restricted Securities to the public without registration, the Company agrees to: 

        (a)   Make
and keep public information available, as those terms are understood and defined in Rule 144 under the Securities Act, at all times after ninety
(90) days after the effective date of the first registration under the Securities Act filed by the Company for an offering of its securities to the general public; 

        (b)   File
with the Commission in a timely manner all reports and other documents required of the Company under the Securities Act and the Exchange Act, at any time after it
has become subject to such reporting requirements; and 

        (c)   So
long as any of the Holders owns Restricted Securities, furnish to Holders of Registrable Securities forthwith upon written request, a written statement by the Company
as to its compliance with the reporting requirements of Rule 144 (at any time after ninety (90) days after the effective date of the first registration statement filed by the Company for
an offering of its securities to the general public), and of the Securities Act and the Exchange Act (at any time after it has become subject to such reporting requirements), a copy of the most recent
annual or quarterly report of the Company, and such other reports and documents of the Company as a Holder of Restricted Securities may reasonably request in availing itself of any rule or regulation
of the Commission allowing such Holder to sell any such securities without registration. 

        15.    Transfer of Registration Rights.    The right to cause the Company to register securities granted hereunder may
be assigned (but only with all related obligations) by a Holder to a transferee or assignee who acquires the lesser of (i) all of such Holder's Registrable Securities or (ii) fifty
thousand (50,000) shares of Registrable Securities (as adjusted for stock splits, stock dividends and the like), provided that the Company is given
written notice of such assignment at the time of or within a reasonable time after said transfer or assignment, and the transferee agrees in writing to be bound by the provisions of this Agreement
regarding the right to register securities. Notwithstanding the foregoing, the rights to cause the Company to register securities may be freely assigned (a) to any partner, active or retired,
of a Holder, where such Holder is a partnership, (b) to any affiliate (as that term is defined in Rule 405 promulgated by the Commission under the Securities Act) of a Holder,
(c) to any officer, director, shareholder or member thereof, where such Holder is a corporation or limited liability company or (d) to the spouse, children, grandchildren or spouse of
such children or grandchildren of any Holder or to trusts for the benefit of any Holder or such persons where the Holder is a natural person, provided
that written notice thereof is promptly given to the Company and that the transferee agrees to be bound by the provisions of this Agreement. 

        16.    Subsequent Grant of Registration Rights.    The Company shall not grant additional registration rights or
rights to have securities other than the Registrable Securities registered under the Securities Act without the written consent of the Holders holding two-thirds of the Registrable
Securities held by all Holders. 

        17.    Information.    

        (a)   The
Company will furnish the following reports to each holder who, along with such holder's affiliate holds at least one million (1,000,000) shares of Preferred Stock
(or Common 

10

 

Stock
issuable upon conversion of the Preferred Stock) (a "Significant Holder"), as adjusted for stock splits, stock dividends and other like
recapitalization events: 

        (i)    As
soon as practicable after the end of each fiscal year of the Company, and in any event within one hundred twenty (120) days thereafter, a consolidated balance
sheet of the Company and its subsidiaries, if any, as at the end of such fiscal year, and consolidated statements of income and cash flows of the Company and its subsidiaries, if any, for such year,
prepared in accordance with generally accepted accounting principles ("GAAP") consistently applied, all in reasonable detail and audited by a "Big 4"
public accountant selected by the Company, unless the Board of Directors, in its reasonable discretion, determines that the auditor need not be a "Big 4" public accountant, in which case the public
accountant shall be an independent public accountant of recognized national standing. 

        (ii)   As
soon as practicable after the end of each calendar quarter and in any event within thirty (30) days thereafter, an unaudited consolidated balance sheet of the
Company and its subsidiaries, if any, as of the end of each calendar quarterly period, and unaudited consolidated statements of income and cash flows of the Company and its subsidiaries for such
period, prepared in accordance with GAAP consistently applied, subject to changes resulting from year-end audit adjustments in reasonable detail and certified by the principal accounting
financial officer of the Company. 

        (iii)  As
soon as practicable after the end of each month and in any event within thirty (30) days thereafter, an unaudited consolidated balance sheet of the Company
and its subsidiaries, if any, as of the end of each monthly period, and unaudited consolidated statements of income and cash flows of the Company and its subsidiaries for such period, compared against
the annual financial plan of the Company described below, and prepared in accordance with GAAP consistently applied, subject to changes resulting from year-end audit adjustments and the
absence of notes, all in reasonable detail and certified by the principal financial or accounting officer of the Company. 

        (iv)  As
soon as practicable after approved by the Board of Directors, but in no event more than thirty (30) days after the end of each fiscal year, an annual
financial plan of the Company for the forthcoming fiscal year. Such financial plan shall provide each Significant Holder with the Company's projections of its quarterly financial statements for the
forthcoming fiscal year. 

        (v)   As
soon as practicable after the end of each quarter, an executive summary of the activities of the Company including, without limitation, marketing, financial, product
development and support and other material activities. 

        (vi)  Prompt
notice of any claim, dispute or litigation which may result in a material and adverse change in the condition, financial or otherwise, customer relations,
employee relations, assets, net worth or results of operations of the Company. 

        (vii) The
rights to information set forth in this Section 17(a) may be transferred to any person acquiring from a
Significant Holder at least one million (1,000,000) shares of Preferred Stock (as adjusted for stock splits, stock dividends and other like recapitalization events)  provided that the transferred
Preferred Stock is not transferred to an unaffiliated third-party who is an actual competitor of the Company in the
reasonable judgment of the Company. 

        (b)   Each
Significant Holder agrees that any information obtained by such Significant Holder pursuant to this  Section 17 which the Company identifies in writing to be proprietary or otherwise confidential
will not be disclosed without the prior written
consent of the Company; provided, however, that the disclosure of any portion of such information by a Significant Holder shall not be considered to be a breach of this Agreement or a waiver of
confidentiality for other purposes if 

11

 

(a) such
information was in the public domain at or subsequent to the time such portion was communicated to the Significant Holder by Company through no fault of the Significant Holder;
(b) such information was rightfully in the Significant Holder's possession free of any obligation of confidence at or subsequent to the time such portion was communicated to the Significant
Holder by Company; (c) such disclosure by the Significant Holder was made in response to a valid order by a court or other governmental body, or (d) such disclosure by the Significant
Holder was otherwise required by law, provided, however, that in those circumstances set forth in (c) and (d) of this subsection, Significant Holder shall provide prompt prior written
notice thereof to Company to enable Company to seek a protective order or otherwise prevent such disclosure. Each Significant Holder further acknowledges and understands that any information so
obtained which may be considered "inside" non-public information will not be utilized by such Significant Holder in connection with purchases and/or sales of the Company's securities
except in compliance with applicable state and federal anti-fraud statutes. 

        18.    Visitation Rights.    In addition to any rights of inspection afforded stockholders by statute or otherwise,
the Company shall permit each Significant Holder, at such Significant Holder's expense, to visit and inspect the Company's properties, to examine its books of account and records and to discuss the
Company's affairs, finances and accounts with its officers, all at such times as are mutually agreed upon by the Significant Holder and the Chief Executive Officer of the Company. 

        19.    Termination of Information and Visitation Rights.    The covenants set forth in  Sections 17 and 18 shall terminate as to Significant Holders and be of no further force or effect
upon the first sale of Common Stock in a bona fide, firm commitment underwriting pursuant to a registration statement under the Securities Act or when the Company first becomes subject to the periodic
reporting requirements of Sections 12(g) or 15(d) of the Exchange Act, whichever event shall first occur. 

        20.    Rights of First Offer.    The Company hereby grants to each Significant Holder and each Common Holder
(individually, an "Offeree" collectively, the "Offerees"), the right of first offer to purchase a pro
rata share of New Securities (as defined in this Section 20) which the Company may, from time to time, propose to sell and issue. Each Offeree's
pro rata share, for purposes of this right of first offer, is the ratio of the number of shares of Common Stock owned by such Offeree immediately prior to the issuance of New Securities, assuming full
conversion of the Preferred Stock, to the total number of shares of Common Stock outstanding immediately prior to the issuance of New Securities, assuming full conversion of all outstanding Preferred
Stock. Each Offeree shall have a right of over-allotment such that if any Offeree fails to exercise its right hereunder to purchase its pro rata share of New Securities, the other Offerees
may purchase the non-purchasing Offeree's portion on a pro rata basis within twenty (20) days from the
date such non-purchasing Offeree fails to exercise its right hereunder to purchase its pro rata share of New Securities. This right of first offer shall be subject to the following
provisions: 

        (a)   "New Securities" shall mean any Common Stock and Preferred Stock of the Company whether or not authorized on the date
hereof, and rights, options, or warrants to purchase Common Stock or Preferred Stock and securities of any type whatsoever that are, or may become, convertible into Common Stock or Preferred Stock;  provided, however, that "New Securities" does not include the following: 

        (i)    shares
or options to purchase shares issued or granted to officers, directors or employees of, or consultants or advisors to, the Company or its subsidiaries pursuant to
the Company's 1999 Stock Option/Stock Issuance Plan (the "Option Plan"); 

        (ii)   shares
issued in connection with a bona fide business acquisition of or by the Corporation that is approved by the Board of Directors, whether by merger, consolidation,
sale of substantially all of the assets, sale or exchange of stock, license, or otherwise; 

12

 

        (iii)  shares
issued upon conversion of shares of the Preferred Stock or Common Stock; 

        (iv)  shares
issued as a dividend or other distribution on the Preferred Stock; 

        (v)   shares
issued in connection with a firm commitment underwritten public offering; 

        (vi)  shares
issued upon exercise of warrants or other securities or rights currently outstanding or issued after the date hereof pursuant to equipment lease financing
transactions, bank financing transactions, or in connection with establishing corporate partnering, strategic alliances or other such business relationships, in each case approved by the Board of
Directors, and for which the principal purpose is not to raise equity funding; and 

        (vii) shares
issued in a transaction described in Article IV.B, Section 3(e) of the Company's Sixth Amended and Restated Certificate of Incorporation, as
amended. 

        (b)   In
the event that the Company proposes to undertake an issuance of New Securities, it shall give each Offeree written notice of its intention, describing the type of New
Securities, the price, and the general terms upon which the Company proposes to issue the same. Each Offeree shall have twenty (20) business days after receipt of such notice to agree to
purchase its pro rata share of such New Securities at the price and upon the terms specified in the notice by giving written notice to the Company and stating therein the quantity of New Securities to
be purchased. Such Offeree's obligation to purchase such New Securities under this Section 20 will be contingent upon the completion of the
issuance of the New Securities substantially in the form as provided in the written notice. 

        (c)   The
Company shall have sixty (60) days after the twenty (20) business days specified above plus any over-allotment period to sell (or enter
into an agreement pursuant to which the sale of New Securities covered thereby shall be closed, if at all, within twenty (20) days from the date of said agreement) the New Securities respecting
which the rights of the Offerees were not exercised (or which were not subject to a right of first offer) at a price and upon terms no more favorable to the purchasers thereof than specified in the
Company's notice. In the event the Company has not sold the New Securities within such sixty (60) day period (or sold and issued New Securities in accordance with the foregoing within twenty
(20) days from the date of such agreement) the Company shall not thereafter issue or sell any New Securities, without first offering such New Securities to the Offerees in the manner provided
above. 

        (d)    Expiration.    The Right of First Offer granted under this  Section 20 shall expire upon the first sale of Common Stock
in a bona fide, firm commitment underwriting pursuant to a registration statement
under the Securities Act with a pre-money valuation of $200,000,000 and with an aggregate offering price of not less than $40,000,000. 

        (e)    Assignability.    This Right of First Offer is nonassignable except to any transferee to whom registration
rights may be transferred pursuant to Section 15 of this Agreement. 

        21.    Covenants.    The Company hereby covenants and agrees with the Preferred Holders as follows: 

        (a)    Proprietary Information and Inventions Agreement.    The Company and each person now or hereafter employed in
any technical capacity by it or any subsidiary with access to confidential information will enter into a Proprietary Information and Inventions Agreement. 

        (b)    Indemnification of Directors.    The Sixth Amended and Restated Certificate of Incorporation, as amended from
time to time, or the Bylaws of the Company will at all times during which any nominee of any of the Preferred Holders serves as a director of the Company provide for indemnification of the directors
and limitations on liability of the directors to the fullest extent permitted under applicable state law. 

13

 

        (c)    Indemnification.    The Company, without limitation as to time, will indemnify and hold harmless and defend
each Preferred Holder and its agents and representatives against, and hold each Preferred Holder and its agents and representatives harmless from, all losses, claims, damages, liabilities, and costs
(including the costs of preparation and attorneys' fees and expenses) (collectively, "Losses") incurred pursuant to any investigation or proceeding by
any Person other than the Company, against the Company, any Preferred Holder or any of their agents and representatives arising out of or in connection with this Agreement or the transactions
contemplated herein and therein (or any other document or instrument executed pursuant hereto or thereto), which investigation or proceeding requires the participation of, or is commenced or filed
against, such Preferred Holders or any of their agents or representatives because of this Agreement and the transactions contemplated herein and therein, other
than to the extent that any Losses are finally determined in such proceeding to be the result of (i) the gross negligence or willful misconduct by such Preferred Holder,
(ii) a breach of a fiduciary duty, if any, owed by such Preferred Holder to the Company, (iii) an act or omission that involves intentional misconduct or a knowing violation of law by
such Preferred Holder, (iv) a material breach by such Preferred Holder of any material provision of this Agreement, (v) a transaction from which the Preferred Holder received an improper
benefit or (vi) Losses incurred by or on behalf of a Preferred Holder's agent or representative who is party to a separate Indemnification Agreement with the Company as to which such
Indemnification Agreement, rather than this Section 22(c), shall apply. 

        (d)    Qualified Small Business Stock.    The Company will use reasonable efforts to comply with the reporting and
record-keeping requirements of Section 1202 of the Internal Revenue Code, any regulations promulgated thereunder and any similar state laws and regulations, and agrees not to repurchase any
stock of the Company if such repurchase would cause such shares not to so qualify as "Qualified Small Business Stock." The provisions of this  Section 21(d) may be waived only by the vote or written
consent of the holders of at least two-thirds of the then outstanding shares
of Preferred Stock. 

        (i)    Independent Accountants.    The Company will retain a "Big 4" independent public accountant firm (unless the
Board of Directors determines, in its reasonable discretion that such auditor need not be a "Big 4" public accountant, in which case the public accountant shall be an independent public accountant of
recognized national standing) who shall audit the Company's financial statements at the end of each fiscal year. In the event the services of the independent public accountants so selected, or any
firm of independent public accountants hereafter employed by the Company, are terminated, the Company will promptly thereafter engage another firm of independent public accountants of recognized
national standing in accordance with the foregoing sentence. 

        (e)    Additional Board Approvals.    Prior to taking any of the following actions, the Company shall first be
required to obtain the approval of its Board of Directors: 

        (i)    appointing
any person as an officer of the Company; 

        (ii)   entering
into employment agreements with any employee unless previously approved by a majority of disinterested members of the Board of Directors or the Compensation
Committee of the Board; 

        (iii)  unless
previously approved by a majority of disinterested members of the Board of Directors or the Compensation Committee of the Board, implementing compensation
programs, including base salaries and bonus programs, for officers and key employees of the Company; 

        (iv)  unless
previously approved by a majority of disinterested members of the Board of Directors or the Compensation Committee of the Board, adopting or approving stock
option 

14

 

programs,
as well as issuing any shares of stock or stock options to employees of, directors of, or any other persons or entities providing services to the Company; 

        (v)   approving
the Company's annual budgets, business and financial plans; 

        (vi)  entering
into lease or purchase agreements for real estate; 

        (vii) entering
into any agreement or series of related agreements including, but not limited to, capital equipment leases or purchases, that require the Company to spend in
excess of $50,000 individually or $250,000 in the aggregate, and which are not contemplated in the then-most recent business plan or budget approved by the Board of Directors. 

        (f)    Board Meetings.    Board of Directors meetings will be held at least four times per year;  provided, however, until the Company is profitable or the Board of Directors otherwise determines,
meetings of the Board of Directors will be held every two months, or six times per year. 

        (g)    Vesting of Certain Securities.    Unless otherwise agreed to by the Board of Directors of the Company, all
stock and other securities issued after the Closing to employees and directors of and consultants and other service providers to the Company shall be subject to the following vesting schedule:
twenty-five percent (25%) of such securities shall vest on the one-year anniversary of the issuance of such securities, with the remaining seventy-five percent
(75%) to vest in equal monthly installments over the next three (3) years. 

        (h)    Option Plan.    The Company will not issue options permitting exercise prior to vesting unless such early
exercise provision and any corresponding right of repurchase provision are specifically discussed with the Company's Board of Directors and the Board of Directors approve such provision. 

        (i)    Issuance of Common Stock.    The Company will not issue shares of Common Stock unless (i) such shares
are subject to a right of first refusal by the Company and (ii) such right of first refusal is not materially different from the Company's right of first refusal as set forth in that certain
form of Stock Purchase Agreement and that certain form of Stock Issuance Agreement as approved by the Board of Directors of the Company. 

        (j)    Payment of Taxes and Trade Debt.    The Company will pay and discharge all taxes, assessments and governmental
charges or levies imposed upon it or upon its income, profits or business, or upon any properties belonging to it, prior to the date on which penalties attach thereto, and all lawful claims which, if
unpaid, might become a lien or charge upon any properties of the Company; provided, however, that the
Company shall not be required to pay any such tax, assessment, charge, levy or claim which is being contested in good faith and by appropriate proceedings if the Company shall have set aside on its
books sufficient reserves, if any, with respect thereto. 

        (k)    Preservation of Corporate Existence.    The Company will preserve and maintain its corporate existence, rights,
franchises and privileges in the jurisdiction of its incorporation, and qualify and remain qualified as a foreign corporation in each jurisdiction in which such qualification is necessary or desirable
in view of its business and operations or the ownership or lease of its properties. Secure, preserve and maintain all licenses and other rights to use Intellectual Property Rights owned or possessed
by it and deemed by the Company to be necessary to the conduct of its business. 

        (l)    Compliance with Laws.    The Company will comply with the requirements of all applicable laws, rules,
regulations and orders of any governmental authority, where noncompliance would have a Material Adverse Effect. 

15

 

        (m)    Keeping of Records and Books of Account.    The Company will keep adequate records and books of account in
which complete entries will be made in accordance with generally accepted accounting principles consistently applied, reflecting all financial transactions of the Company, and in which, for each
fiscal year, all proper reserves for depreciation, depletion, returns of merchandise, obsolescence, amortization, taxes, bad debts and other purposes in connection with its business shall be made. 

        (n)    Maintenance of Properties.    The Company will maintain and preserve all of its properties and assets,
necessary for the proper conduct of its business, in good repair, working order and condition, ordinary wear and tear excepted. 

        (o)    Bylaws.    The Company will at all times, cause the bylaws of the Company to provide that, unless otherwise
required by the laws of the State of Delaware, (i) any two directors and (ii) any holder or holders of at least 25% of the outstanding Preferred Shares, shall have the right to call a
meeting of the Board of Directors or stockholders. 

        (p)    Expenses of Directors.    The Company will promptly reimburse in full, each director of the Company who is not
an employee of the Company for all of his reasonable out-of-pocket expenses incurred in attending each meeting of the Board of Directors of the Company or any committee
thereof. 

        (q)    Assignment Agreements.    The Company will obtain from each named inventor for any patent application filed by
or on behalf of the Company an assignment reasonably acceptable to counsel for the Company which assigns to the Company all rights in and to any such patent application and patent issuing therefrom. 

        (r)    Termination of Covenants.    The covenants of the Company set forth in  Sections 21(d), (h), (i) and (j) shall terminate in all respects on the date of the closing of an
initial firm commitment underwritten public offering pursuant to an effective registration statement under the Securities Act, covering the offer and sale of the Company's Common Stock. 

        (s)    Registration Rights of Comerica Bank.    The parties hereto acknowledge that pursuant to that certain warrant
to purchase shares of the Company's Series A Preferred Stock and Series P Common Stock, issued by the Company to Comerica Bank—California
("Comerica") in accordance with the Loan and Security Agreement, dated April 3, 2003, by and between the Company and Comerica, Comerica is
entitled to "piggy back" registration rights in accordance with the terms of this Agreement and shall be deemed a "Holder" under this Agreement for purposes of  Section 6 of this Agreement. The
Company, upon the request of Comerica, may provide Comerica with a joinder agreement deeming Comerica a "Holder"
for purposes of Section 6 of this Agreement. 

        (t)    Assignment of Purchase Rights.    In the event that the Company obtains a right to purchase shares of its
capital stock held by Environmental Defense Fund or its affiliates in connection with a proposed transfer of such shares, and the Company does not intend to exercise such right in full, then the
Company shall, in a timely manner, notify each Preferred Holder who holds shares of Series C Preferred Stock (the "Series C Holders") of
such fact and assign such right to the Series C Holders pro rata based on the number of shares of Series C Preferred Stock held by such Series C Holders, with a full
oversubscription right such that any shares not subscribed for by any Series C Holders shall be available for purchase by the Series C Holders exercising such rights in full. 

        22.    Election of Directors.    Each of the parties hereto agrees to vote all of his, her or its Shares (and attend,
in person or by proxy, all meetings of stockholders called for the purpose of electing directors), and the Company agrees to take all actions (including, but not limited to the nomination of 

16

 

specified
persons) to cause and maintain the election to the Board of Directors of the Company, to the extent permitted pursuant to the Company's certificate of incorporation, the following: 

        (i)    except
as set forth in Section 22(vi) below, three (3) persons designated by the holders of a majority of the Company's Series P Common
holders and Series A Convertible Preferred holders, voting on an as-if-converted to Series P Common Stock basis (the "Series P
Directors"), one (1) of whom shall be designated by Adams Street V, L.P. (who shall initially be George Spencer), one (1) of whom shall be designated by Granite Ventures (who
shall initially be Chris Hollenbeck), and one (1) of whom shall be designated by Austin Ventures (who shall initially be Tom Ball); 

        (ii)   one
(1) person designated by the Stockholders' Agent (as defined in that certain Merger Agreement, dated January 10, 2007, between the Company, GetActive
Software, Inc. and Robert Epstein, as Stockholders' Agent (the "Merger Agreement")) who shall represent the holders of the Series Q Common
Stock, Series R Common Stock and Series S Common Stock, and who shall initially be Sheeraz Haji (the "QRS Director"); 

        (iii)  one
(1) person designated by a majority of the Board of Directors, including the approval of at least one of the Series P Directors and either the QRS
Director or the Series C Director, and who shall initially be Vinay Bhagat; 

        (iv)  one
(1) person who shall at all times be the then current Chief Executive Officer of the Company (the "CEO
Director"); 

        (v)   one
(1) person designated by El Dorado Ventures VI, L.P. (the "Series C Director") and who shall initially
be Scott Irwin; and 

        (vi)  after
the date hereof, the Board of Directors shall undertake the process of identifying one (1) person approved by a majority of the existing Board of
Directors, including the approval of at least one of the Series P Directors and the QRS Director, who shall have relevant experience in the industry and have no affiliation with the Company and
who shall replace one (1) Series P Director (the "Industry Director") (and the entity previously entitled to designate such
Series P Director shall no longer retain such right. Thereafter, the Industry Director shall be designated by a majority of the existing Board of
Directors, including the approval of at least one of the Series P Directors and the QRS Director, who shall have relevant experience in the industry and have no affiliation with the Company. 

        Each
of the parties further covenants and agrees to vote, to the extent possible, all Shares so that the authorized number of members of the Company's Board of Directors shall consist of
seven (7) members. 

        In
the absence of any designation from the persons or groups so designating directors as specified above, the director previously designated by them and then serving shall be
re-elected if still eligible to serve as provided herein. 

        No
party hereto shall vote to remove any member of the Board of Directors designated in accordance with the aforesaid procedure unless the persons or groups so designating directors as
specified above so vote, and, if such persons or groups so vote then the non-designating party or parties shall likewise so vote. In the event that the person serving as the director to be
elected as the CEO Director ceases to serve as the Chief Executive Officer of the Company, each of the parties hereto agrees to vote all of its Shares for the removal of such director at the request
of a majority of the Board of Directors, excluding the director to be removed. 

        The
rights set forth in this Section 22 shall expire upon the first sale of Common Stock pursuant to a registration statement under
the Securities Act. 

17

 

        23.    Board Observer Rights.    The Company shall invite one (1) representative designated from time to time
by the Stockholders' Agent (as defined in the Merger Agreement), who shall initially be William Pease, and one (1) representative designated by Rembrandt Ventures (together, the
"Observers") who shall initially be Douglas Schrier, to attend in a nonvoting observer capacity all meetings of the Board of Directors of the Company or
of the committees thereof and, in this respect, shall give the Observers copies of all notices and other materials that they provide generally to the members of the Board of Directors of the Company
(or such committees thereof); provided, however, that the Company reserves the right to exclude the Observers from access to any material or meeting or portion thereof if a majority of the Board of
Directors (or a committee thereof) believes that such exclusion is reasonably necessary in the performance of its duties, to preserve the attorney-client privilege, to protect highly confidential
proprietary information or for other similar reasons. 

        The
rights set forth in this Section 23 shall expire upon the first sale of Common Stock pursuant to a registration statement under
the Securities Act. 

        24.    Non-Disclosure of Investment Interests.    The Company hereby covenants and agrees that, except as
otherwise required by law, no information concerning the identity of any Preferred Holder as an investor or interested party to the Company, including but not limited to information distributed in any
press release, marketing or advertising materials, loan applications and general business development, will be disclosed by the Company or its agents without the prior written consent of such
Preferred Holder, which consent shall be at that Preferred Holder's sole discretion. 

        25.    Governing Law.    This Agreement and the legal relations between the parties arising hereunder shall be
governed by and interpreted in accordance with the laws of the State of Delaware (without resort to the conflict of law principles thereof). 

        26.    Entire Agreement.    This Agreement constitutes the full and entire understanding and agreement between the
parties regarding the rights provided herein. The Prior Agreement is hereby terminated in its entirety and shall be of no further force or effect. Except as otherwise expressly provided herein, the
provisions hereof shall inure to the benefit of, and be binding upon, the successors, assigns, heirs, executors and administrators of the parties hereto. 

        27.    Notices, Etc.    All notices, requests, consents and other communications under this Agreement shall be in
writing and shall be deemed delivered on the date of delivery, when delivered personally or by overnight courier or sent by telegram or confirmed fax, or seventy-two (72) hours after being
deposited with the United States Post Office, as First Class certified or registered mail, return receipt requested, postage prepaid, to the following addresses: (i) if to a Preferred Holder:
at the address below such Preferred Holder's name on Schedule I attached hereto, or at such other address as the Preferred Holder may designate
by ten (10) days advance written notice to the other parties hereto; (ii) if to Common Holder, at the address below such Common Holder's name on  Schedule II attached hereto, or at such other
address as the Common Holder may designate by ten (10) days' advance written notice to the
other parties hereto, or (iii) (iv) if to the Company, to its principal place of business, 11921 N. Mopac Expressway, Ste. 200, Austin, TX 78759, or the address of any registered agent and with
a copy (which shall not constitute notice) to DLA Piper US LLP, 1221 South MoPac Expressway, Suite 400, Austin, TX 78746-6875, attn: John Gilluly, facsimile
(512) 457-7001. 

        28.    Counterparts; Facsimile Signatures.    This Agreement may be executed in any number of counterparts, each of
which shall be an original, but all of which together shall constitute one instrument. Signatures transmitted via facsimile shall be deemed originals for purposes of this Agreement. 

        29.    Amendment.    Unless otherwise stated in the foregoing, any provision of this Agreement may be amended, waived
or modified only upon the written consent of (i) the Company, and (ii) holders of at least two-thirds in interest of the Preferred Stock;  provided, however, that any amendment which 

18

 

uniquely
and adversely affects (i) the Common Holders or (ii) the QRS Holders (as defined in the Company's Sixth Amended and Restated Certificate of Incorporation), as the case may be,
shall not be effective against such respective holders without the written consent of the holders of at least a majority in interest of such holders; and provided, further, that any amendment to  Section 22 that would adversely alter the right of any party or group of parties shall require the written consent of such party or group of
parties. Any amendment or modification effected in accordance with this Section 29 shall be binding upon each party hereto and each party and the
Company. Any amendment, waiver or modification not effected in accordance with this Section 28 shall be null and void. 

        30.    Independent Counsel.    Each party acknowledges and agrees that DLA Piper US LLP is and has acted solely as
counsel to the Company, and not to such party, in connection with the transactions contemplated by this Agreement. Each party further acknowledges and agrees that such party has been represented by
and consulted with, or has had reasonable opportunity to be represented by and consulted with, independent counsel of its own choosing throughout all negotiations that preceded the execution and
delivery of this Agreement. 

Remainder of Page Intentionally Left Blank  

19

  
        IN WITNESS WHEREOF, the undersigned has executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

 

					
	 	 	 COMPANY:
	

 	
 	
 CONVIO, INC.

a Delaware corporation
	

 	
 	
 By:	
 	
 /s/ Gene Austin

  Gene Austin

Chief Executive Officer

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

			
	 	 	 COMMON HOLDERS:
	

 	
 	
 /s/ Vinay Bhagat

  Vinay Bhagat
	

 	
 	
  

  David Crooke
	

 	
 	
 /s/ Gene Austin

  Gene Austin
	

 	
 	
 /s/ Jim Offerdahl

  Jim Offerdahl

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

			
	 	 	 COMMON HOLDERS (continued):
	

 	
 	
 

  Sheeraz Haji
	

 	
 	
 /s/ William Pease

  William Pease

 

 

  
        IN WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

 

					
	 	 	 PREFERRED HOLDERS:
	

 	
 	
 ADAMS STREET V, L.P.
	

 	
 	
 By:	
 	
 Adams Street Partners, LLC,

its General Partner
	

 	
 	
 By:	
 	
 /s/ Jeffrey T. Diehl

  Jeffrey T. Diehl

Partner
	

 	
 	
 EL DORADO VENTURES VI, L.P.
	

 	
 	
 By:	
 	
 

 
	 	 	 Name:	 	  

 
	 	 	 Title:	 	 

 
	

 	
 	
 EL DORADO TECHNOLOGY '01, L.P.
	 	 	 By:	 	  

 
	 	 	 Name:	 	 

 
	 	 	 Title:	 	  

 
	

 	
 	
 REMBRANDT VENTURES PARTNERS II, L.P.
	

 	
 	
 By:	
 	
  

 
	 	 	 Name:	 	 

 
	 	 	 Title:	 	  

 

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

					
	 	 	 PREFERRED HOLDERS:
	

 	
 	
 ADAMS STREET V, L.P.
	

 	
 	
 By:	
 	
 Adams Street Partners, LLC,

its General Partner
	

 	
 	
 By:	
 	
 

  George H. Spencer, III

Partner
	

 	
 	
 EL DORADO VENTURES VI, L.P.
	

 	
 	
 By:	
 	
 /s/ Scott Irwin

 
	 	 	 Name:	 	 Scott Irwin

 
	 	 	 Title:	 	 General Partner

 
	

 	
 	
 EL DORADO TECHNOLOGY '01, L.P.
	

 	
 	
 By:	
 	
 /s/ Scott Irwin

 
	 	 	 Name:	 	 Scott Irwin

 
	 	 	 Title:	 	 General Partner

 
	

 	
 	
 REMBRANDT VENTURES PARTNERS II, L.P.
	

 	
 	
 By:	
 	
 /s/ Douglas Schrier

 
	 	 	 Name:	 	 Douglas Schrier

 
	 	 	 Title:	 	 General Partner

 

 

 

  
        IN WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

 

					
	 	 	 PREFERRED HOLDERS:
	

 	
 	
 REMBRANDT VENTURES PARTNERS EXPANSION FUND, L.P.
	

 	
 	
 By:	
 	
 /s/ Douglas Schrier

 
	 	 	 Name:	 	 Douglas Schrier

 
	 	 	 Title:	 	 General Partner

 

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

					
	 	 	 PREFERRED HOLDERS (continued):
	

 	
 	
 GRANITE VENTURES, L.P.
	

 	
 	
 By:	
 	
 Granite Management, L.L.C.,

Its General Partner
	

 	
 	
 By:	
 	
 /s/ Jackie Berterretche

 
	 	 	 Name:	 	 Jackie Berterretche

 
	 	 	 Title:	 	 Attorney-in-Fact

 
	

 	
 	
 ADOBE VENTURES IV, L.P.
	

 	
 	
 By:	
 	
 Adobe Ventures Management IV, LLC

Its General Partner
	

 	
 	
 By:	
 	
 /s/ Jackie Berterretche

 
	 	 	 Name:	 	 Jackie Berterretche

 
	 	 	 Title:	 	 Attorney-in-Fact

 
	

 	
 	
 TODD U.S. VENTURES, LLC
	

 	
 	
 By:	
 	
 H&Q Todd Ventures Management, LLC
	

 	
 	
 By:	
 	
 /s/ Jackie Berterretche

 
	 	 	 Name:	 	 Jackie Berterretche

 
	 	 	 Title:	 	 Attorney-in-Fact

 

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

					
	 	 	 PREFERRED HOLDERS (continued):
	

 	
 	
 AUSTIN VENTURES VI, L.P.
	

 	
 	
 By:	
 	
 AV Partners VI, LP,

Its General Partner
	

 	
 	
 By:	
 	
 

 
	 	 	 Name:	 	  

 
	 	 	 Title:	 	 

 
	

 	
 	
 AUSTIN VENTURES VI

AFFILIATES FUND, L.P.
	

 	
 	
 By:	
 	
 AV Partners VI, LP,

Its General Partner
	

 	
 	
 By:	
 	
  

 
	 	 	 Name:	 	 

 
	 	 	 Title:	 	  

 
	

 	
 	
 SILVERTON PARTNERS III, L.P.
	

 	
 	
 By:	
 	
 /s/ William Wood

  William Wood

General Partner
	

 	
 	
 LIBERTY MUTUAL INSURANCE COMPANY
	

 	
 	
 By:	
 	
  

  Ronald D. Ulich

Vice President

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

					
	 	 	 PREFERRED HOLDERS (continued):
	

 	
 	
 AUSTIN VENTURES VI, L.P.
	

 	
 	
 By:	
 	
 AV Partners VI, LP,

Its General Partner
	 	 	 By:	 	  

 
	 	 	 Name:	 	  

 
	 	 	 Title:	 	  

 
	

 	
 	
 AUSTIN VENTURES VI

AFFILIATES FUND, L.P.
	

 	
 	
 By:	
 	
 AV Partners VI, LP,

Its General Partner
	

 	
 	
 By:	
 	
  

 
	 	 	 Name:	 	  

 
	 	 	 Title:	 	 

 
	

 	
 	
 SILVERTON PARTNERS III, L.P.
	

 	
 	
 By:	
 	
 

  William Wood

General Partner
	

 	
 	
 LIBERTY MUTUAL INSURANCE COMPANY
	

 	
 	
 By:	
 	
 /s/ Ronald D. Ulich

  Ronald D. Ulich

Vice President
	

 	
 	
 LMIA COINVESTMENT L.P.
	

 	
 	
 By:	
 	
 Liberty Mutual Insurance Company,

Its general partner
	

 	
 	
 By:	
 	
 /s/ Ronald D. Ulich

  Ronald D. Ulich

Vice President

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

					
	 	 	 PREFERRED HOLDERS (continued):
	

 	
 	
 GRANITE VENTURES, L.P.
	

 	
 	
 By:	
 	
 Granite Management, L.L.C.,

Its General Partner
	

 	
 	
 By:	
 	
 /s/ Jackie Berterretche

 
	 	 	 Name:	 	 Jackie Berterretche

 
	 	 	 Title:	 	 Attorney-in-Fact

 
	

 	
 	
 ADOBE VENTURES IV, L.P.
	

 	
 	
 By:	
 	
 Adobe Ventures Management IV, LLC

Its General Partner
	

 	
 	
 By:	
 	
 /s/ Jackie Berterretche

 
	 	 	 Name:	 	 Jackie Berterretche

 
	 	 	 Title:	 	 Attorney-in-Fact

 
	

 	
 	
 TODD U.S. VENTURES, LLC
	

 	
 	
 By:	
 	
 H&Q Todd Ventures Management, LLC
	

 	
 	
 By:	
 	
 /s/ Jackie Berterretche

 
	 	 	 Name:	 	 Jackie Berterretche

 
	 	 	 Title:	 	 Attorney-in-Fact

 

 

 

  
        IN WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

 

					
	 	 	 PREFERRED HOLDERS:
	

 	
 	
 HORIZON TECHNOLOGY FUNDING COMPANY II LLC
	

 	
 	
 By:	
 	
 Horizon Technology Finance, LLC, its member and agent
	

 	
 	
 By:	
 	
 /s/ Robert D. Pomeroy, Jr.

 
	 	 	 Name:	 	 Robert D. Pomeroy, Jr.

 
	 	 	 Title:	 	 Managing Member

 

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

			
	 	 	 PREFERRED STOCKHOLDERS (continued):
	

 	
 	
 /s/ Sheeraz Haji

  Sheeraz Haji
	

 	
 	
 /s/ Pete Kirkwood

  Pete Kirkwood
	

 	
 	
 /s/ Robert Epstein

  Robert Epstein
	

 	
 	
  

  James Pooley
	

 	
 	
  

  Samuel Kingsland
	

 	
 	
 

  Lisa Gansky
	

 	
 	
  

  Cristina Morgan
	

 	
 	
 

  David Golden

Wilner Trust
	

 	
 	
  

  Nicholas Allen
	

 	
 	
  

  Mary Krackeler

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

					
	 	 	 PREFERRED HOLDERS (continued):
	

 	
 	
 Pacific Partners USA, L.P.
	

 	
 	
 By:	
 	
 /s/ Travis Nelson

 
	 	 	 Name:	 	 Travis Nelson

 
	 	 	 Title:	 	 Managing Director

 

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

					
	 	 	 PREFERRED HOLDERS (continued):
	

 	
 	
 Casilli Investment Partners
	

 	
 	
 By:	
 	
 /s/ Gerald S. Casilli

 
	 	 	 Name:	 	 Gerald S. Casilli

 
	 	 	 Title:	 	 Partner

 
	

 	
 	
 Casilli Revocable Trust
	

 	
 	
 By:	
 	
 /s/ Gerald S. Casilli

 
	 	 	 Name:	 	 Gerald S. Casilli

 
	 	 	 Title:	 	 Trustee

 
	

 	
 	
/s/ Michelle A. Casilli

  Michelle A. Casilli
	

 	
 	
/s/ Gerard A. Casilli

  Gerard A. Casilli

 

 

  
        IN WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

 

			
	 	 	  

  Alice Hendricks
	

 	
 	
 

  Amanda Dramstad
	

 	
 	
 /s/ Angelica Broaddus

  Angelica Broaddus
	

 	
 	
 

  Avi Schaeffer
	

 	
 	
  

  Barker Trust
	

 	
 	
  

  Brian Trelstad
	

 	
 	
  

  Bruce Keilin
	

 	
 	
  

  Charles Berman
	

 	
 	
 

  Christopher Dworin
	

 	
 	
 /s/ Curtis Below

  Curtis Below

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

			
	 	 	 /s/ Dan Landy

  Dan Landy
	

 	
 	
 /s/ David Abercrombie

  David Abercrombie
	

 	
 	
  

  David Moynihan
	

 	
 	
 

  Debra Perlson
	

 	
 	
  

  Douglas Chuchro
	

 	
 	
  

  Environmental Defense Fund
	

 	
 	
  

  Francois Furstenberg
	

 	
 	
  

  Gregory Neichin
	

 	
 	
 

  Irwin Lieber
	

 	
 	
  

  Jackson Horton

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

			
	 	 	  

  James Kim
	

 	
 	
 

  James Koshland
	

 	
 	
  

  James Swanson
	

 	
 	
 

  JC Severiens
	

 	
 	
  

  Jeff Raleigh
	

 	
 	
  

  Jenny Kim
	

 	
 	
  

  Jospeh Walsmith
	

 	
 	
 /s/ Karl Goldstein

  Karl Goldstein
	

 	
 	
 /s/ Ken Leiserson

  Ken Leiserson
	

 	
 	
  

  Kenneth Thornton
	

 	
 	
 /s/ Kristin Lawton

  Kristin Lawton

 

 

  
        IN WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

 

			
	 	 	  

  Larry Kontz
	

 	
 	
 

  Lefeber Investment Partnership
	

 	
 	
  

  Lori Painter
	

 	
 	
 

  Mal Warwick Trust
	

 	
 	
  

  Mami Nomura
	

 	
 	
 

  Michael Baird Trust
	

 	
 	
 /s/ Michael Schwarz

  Michael Schwarz
	

 	
 	
  

  Nancy Abercrombie
	

 	
 	
  

  New Millennium Capital Partners II, LLC
	

 	
 	
  

  Patrick Kelly

 

 

        IN
WITNESS WHEREOF, the undersigned have executed this Fifth Amended and Restated Investors' Rights Agreement as of the date set forth above. 

 

			
	 	 	  

  Todd Lash
	

 	
 	
 /s/ Tom Krackeler

  Tom Krackeler
	

 	
 	
 /s/ Tri Tran

  Tri Tran
	

 	
 	
 

  Vernon George
	

 	
 	
  

  Woodland Venture Fund
	

 	
 	
 /s/ Yoshinobu Sugawara

  Yoshinobu Sugawara

 

 

 

 

			
	 	 	  

  Lefeber Investment Partnership
	

 	
 	
 

  Lori Painter
	

 	
 	
  

  Mal Warwick Trust
	

 	
 	
 /s/ Mami Nomura

  Mami Nomura
	

 	
 	
  

  Michael Baird Trust
	

 	
 	
  

  Michael Schwarz
	

 	
 	
  

  Nancy Abercrombie

 

 

 
 

  Schedule I
  SCHEDULE OF COMMON HOLDERS    
    

 

 

														
	 
	 	Shares of Common Stock Held (as of April 10, 2007) 	 
	Common Holder

 
	 	P 	 	Q 	 	R 	 	S 	 
	Vinay Bhagat

c/o Convio, Inc.

11921 N. Mopac, Suite 400

Austin, Texas 78759	 	 	1,088,187	 	 	 	 	 	 	 	 	 	 
	
David Crooke

c/o Convio, Inc.

11921 N. Mopac, Suite 400

Austin, Texas 78759	
 	
 	
130,000	
 	
 	

 	
 	
 	

 	
 	
 	

 	
 
	
Gene Austin

c/o Convio, Inc.

11921 N. Mopac, Suite 400

Austin, Texas 78759	
 	
 	
1,256,374	
 	
 	

 	
 	
 	

 	
 	
 	

 	
 
	
Jim Offerdahl

c/o Convio, Inc.

11921 N. Mopac, Suite 400

Austin, Texas 78759	
 	
 	
450,000	
 	
 	

 	
 	
 	

 	
 	
 	

 	
 
	
Sheeraz Haji	
 	
 	
 	
 	
 	
331	
 	
 	
12,265	
 	
 	
385,826	
 
	
William S. Pease	
 	
 	
 	
 	
 	
 	
 	
 	
 	
 	
 	
803,805	
 

 

 

 
 

  Schedule II
  SCHEDULE OF PREFERRED HOLDERS    
    

 

 

																							
	 
	 	Registrable Securities (as of April 10, 2007) 	 
	 
	 	Preferred Stock 	 	Common Stock 	 
	Preferred Holder

 
	 	Series A 	 	Series B 	 	Series C 	 	Series P 	 	Series Q 	 	Series R 	 	Series S 	 
	Adams Street Partners V, L.P.

One North Wacker Drive, Suite 2200

Chicago, IL 60606-2807

Attn: George H. Spencer, III	 	 	1,624,999	 	 	 	 	 	194,438	 	 	1,389,517	 	 	 	 	 	 	 	 	 	 
	Austin Ventures VI, LP

300 West Sixth Street, Suite 2300

Austin, Texas 78701

Attn: Tom Ball	 	 	2,318,786	 	 	 	 	 	155,375	 	 	3,008,306	 	 	 	 	 	 	 	 	 	 
	Austin Ventures VI Affiliates Fund, LP

300 West Sixth Street, Suite 2300

Austin, Texas 78701

Attn: Tom Ball	 	 	65,215	 	 	 	 	 	4,369	 	 	84,607	 	 	 	 	 	 	 	 	 	 
	Silverton Partners III, L.P.

1000 Rio Grande Street

Austin, TX 78701

Attn: William Wood	 	 	735,750	 	 	 	 	 	112,891	 	 	1,014,481	 	 	 	 	 	 	 	 	 	 
	Roliff H. Purrington, Jr.

Mayor, Day, Caldwell & Keeton, LLP

100 Congress Avenue, Suite 1500

Austin, TX 78701-4042	 	 	6,999	 	 	 	 	 	 	 	 	7,102	 	 	 	 	 	 	 	 	 	 
	William A. Sahlman, Ph.D.

Baker Library 373

Harvard Business School

Soldiers Field

Boston, MA 02163	 	 	4,999	 	 	 	 	 	 	 	 	5,073	 	 	 	 	 	 	 	 	 	 
	Philip Cannon	 	 	1,999	 	 	 	 	 	 	 	 	2,029	 	 	 	 	 	 	 	 	 	 
	Ashish Dhawan

ChrysCapital

Suite 101, The Oberoi

Dr. Zakir Hussain Marg

New Delhi—110003

India	 	 	1,999	 	 	 	 	 	 	 	 	2,029	 	 	 	 	 	 	 	 	 	 
	Sandeep Nanda	 	 	1,999	 	 	 	 	 	 	 	 	2,077	 	 	 	 	 	 	 	 	 	 
	Ajit Nedungadi

TA Associates

High Street Tower, Suite 2500

125 High Street

Boston, MA 02110	 	 	1,999	 	 	 	 	 	 	 	 	2,029	 	 	 	 	 	 	 	 	 	 
	Granite Ventures, L.P.

One Bush Street, Suite 1350

San Francisco, CA 94104

Attn: Chris Hollenbeck	 	 	1,418,749	 	 	 	 	 	207,273	 	 	2,133,029	 	 	 	 	 	 	 	 	 	 
	Adobe Ventures IV, L.P.

c/o Granite Ventures, L.P.

One Bush Street, Suite 1350

San Francisco, CA 94104

Attn: Chris Hollenbeck	 	 	1,276,875	 	 	 	 	 	 	 	 	1,919,726	 	 	 	 	 	 	 	 	 	 
	Todd U.S. Ventures, LLC

c/o Granite Ventures, L.P.

One Bush Street, Suite 1350

San Francisco, CA 94104

Attn: Chris Hollenbeck	 	 	141,874	 	 	 	 	 	 	 	 	213,302	 	 	 	 	 	 	 	 	 	 
	Neil Webber	 	 	126,249	 	 	 	 	 	 	 	 	144,040	 	 	 	 	 	 	 	 	 	 

 

 

 

 

																							
	 
	 	Registrable Securities (as of April 10, 2007) 	 
	 
	 	Preferred Stock 	 	Common Stock 	 
	Preferred Holder

 
	 	Series A 	 	Series B 	 	Series C 	 	Series P 	 	Series Q 	 	Series R 	 	Series S 	 
	Brobeck, Phleger & Harrison LLP

(Associates Stock Fund)

Andrews Kurth LLP

111 Congress Avenue, Suite 1700

Austin, TX 78701

Attn: J. Matthew Lyons, Esq.	 	 	1,749	 	 	 	 	 	 	 	 	1,523	 	 	 	 	 	 	 	 	 	 
	Austin Tighe

Andrews Kurth LLP

111 Congress Avenue, Suite 1700

Austin, TX 78701

Attn: J. Matthew Lyons, Esq. 	 	 	437	 	 	 	 	 	 	 	 	380	 	 	 	 	 	 	 	 	 	 
	Carmelo M. Gordian

Andrews Kurth LLP

111 Congress Avenue, Suite 1700

Austin, TX 78701

Attn: J. Matthew Lyons, Esq.	 	 	874	 	 	 	 	 	 	 	 	761	 	 	 	 	 	 	 	 	 	 
	Charles S. Baker

Andrews Kurth LLP

111 Congress Avenue, Suite 1700

Austin, TX 78701

Attn: J. Matthew Lyons, Esq.	 	 	437	 	 	 	 	 	 	 	 	380	 	 	 	 	 	 	 	 	 	 
	J. Matthew Lyons

Andrews Kurth LLP

111 Congress Avenue, Suite 1700

Austin, TX 78701

Attn: J. Matthew Lyons, Esq.	 	 	437	 	 	 	 	 	 	 	 	380	 	 	 	 	 	 	 	 	 	 
	Kinloch Gill III

Andrews Kurth LLP

111 Congress Avenue, Suite 1700

Austin, TX 78701

Attn: J. Matthew Lyons, Esq.	 	 	437	 	 	 	 	 	 	 	 	380	 	 	 	 	 	 	 	 	 	 
	Robert DeBerardine

Andrews Kurth LLP

111 Congress Avenue, Suite 1700

Austin, TX 78701

Attn: J. Matthew Lyons, Esq.	 	 	874	 	 	 	 	 	 	 	 	761	 	 	 	 	 	 	 	 	 	 
	Virtual CFO

4601 Spicewood Springs Road

Building II, Ste 100

Austin, TX 78759-8598

Attn: Ellen Wood	 	 	4,374	 	 	 	 	 	 	 	 	3,808	 	 	 	 	 	 	 	 	 	 
	Liberty Mutual Insurance Company

175 Berkeley Street

Boston, MA 02117

Attn: Ronald D. Ulich	 	 	887,499	 	 	 	 	 	 	 	 	1,674,844	 	 	 	 	 	 	 	 	 	 
	LMIA Coinvestment L.P.

175 Berkeley Street

Boston, MA 02117

Attn: Ronald D. Ulich	 	 	 	 	 	 	 	 	165,272	 	 	 	 	 	 	 	 	 	 	 	 	 
	Sheeraz Haji	 	 	 	 	 	1,900	 	 	 	 	 	 	 	 	331	 	 	12,265	 	 	385,826	 
	Pete Kirkwood	 	 	 	 	 	13,849	 	 	31,948	 	 	 	 	 	2,418	 	 	28,707	 	 	18,219	 
	Robert Epstein	 	 	 	 	 	19,008	 	 	 	 	 	 	 	 	3,319	 	 	430,674	 	 	 	 
	James Pooley	 	 	 	 	 	13,398	 	 	 	 	 	 	 	 	2,340	 	 	52,716	 	 	 	 
	Samuel Kingsland	 	 	 	 	 	9,504	 	 	 	 	 	 	 	 	1,659	 	 	54,610	 	 	 	 
	Lisa Gansky	 	 	 	 	 	3,804	 	 	 	 	 	 	 	 	664	 	 	175,007	 	 	 	 
	Cristina Morgan	 	 	 	 	 	8,720	 	 	 	 	 	 	 	 	1,523	 	 	42,819	 	 	 	 
	David Golden

Wilner Trust	 	 	 	 	 	3,832	 	 	 	 	 	 	 	 	669	 	 	21,499	 	 	 	 
	Nicholas Allen	 	 	 	 	 	11,107	 	 	 	 	 	 	 	 	1,939	 	 	15,136	 	 	 	 
	Mary Krackeler	 	 	 	 	 	7,603	 	 	 	 	 	 	 	 	1,327	 	 	9,394	 	 	 	 
	William Krackeler	 	 	 	 	 	7,603	 	 	 	 	 	 	 	 	1,327	 	 	9,394	 	 	 	 

 

 

 

 

																							
	 
	 	Registrable Securities (as of April 10, 2007) 	 
	 
	 	Preferred Stock 	 	Common Stock 	 
	Preferred Holder

 
	 	Series A 	 	Series B 	 	Series C 	 	Series P 	 	Series Q 	 	Series R 	 	Series S 	 
	Chris Buchbinder	 	 	 	 	 	4,990	 	 	 	 	 	 	 	 	871	 	 	15,031	 	 	 	 
	Kerry Propper	 	 	 	 	 	9,504	 	 	 	 	 	 	 	 	1,659	 	 	22,965	 	 	 	 
	Michael Shellenberger	 	 	 	 	 	2,851	 	 	 	 	 	 	 	 	497	 	 	11,482	 	 	 	 
	Tim Kirkwood	 	 	 	 	 	6,636	 	 	 	 	 	 	 	 	1,159	 	 	11,482	 	 	 	 
	Fowler Trust	 	 	 	 	 	8,303	 	 	 	 	 	 	 	 	1,450	 	 	16,076	 	 	 	 
	Vaishali Patel	 	 	 	 	 	1,900	 	 	 	 	 	 	 	 	332	 	 	3,653	 	 	 	 
	Burwen Trust	 	 	 	 	 	9,504	 	 	 	 	 	 	 	 	1,659	 	 	18,268	 	 	 	 
	Asha Haji	 	 	 	 	 	6,328	 	 	 	 	 	 	 	 	1,105	 	 	10,960	 	 	 	 
	El Dorado Ventures VI, L.P.

El Dorado Ventures

2440 Sand Hill Road, Suite 200

Menlo Park, CA 94025

Attn: Scott Irwin	 	 	 	 	 	1,688,754	 	 	1,209,128	 	 	 	 	 	294,939	 	 	 	 	 	 	 
	El Dorado Technology '01, L.P.

El Dorado Ventures

2440 Sand Hill Road, Suite 200

Menlo Park, CA 94025

Attn: Scott Irwin	 	 	 	 	 	51,506	 	 	35,878	 	 	 	 	 	8,995	 	 	 	 	 	 	 
	Pacific Partners USA LLP

2250 Hyde Street, #5

San Francisco, CA 94109

Attn: Gordon Rubenstein

and

TowerBrook Capital Partners

430 Park Avenue, 6th Floor

New York, NY 10022

Fax: (917) 591-3269

Attn: Travis Nelson	 	 	 	 	 	997,874	 	 	 	 	 	 	 	 	174,277	 	 	 	 	 	 	 
	Rembrandt Ventures Partners II, L.P.

2200 Sand Hill Road, Suite 1600

Menlo Park, CA 94025

Attn: Doug Schrier and Gerald Casilli	 	 	 	 	 	333,609	 	 	467,252	 	 	 	 	 	58,264	 	 	 	 	 	 	 
	Rembrandt Ventures Partners Expansion Fund, L.P.

2200 Sand Hill Road, Suite 1600

Menlo Park, CA 94025

Attn: Doug Schrier and Gerald Casilli	 	 	 	 	 	 	 	 	155,751	 	 	 	 	 	 	 	 	 	 	 	 	 
	Abdul Haji	 	 	 	 	 	349	 	 	 	 	 	 	 	 	61	 	 	5,741	 	 	 	 
	Casilli Investment Partners	 	 	 	 	 	3,323	 	 	 	 	 	 	 	 	580	 	 	54,512	 	 	 	 
	Casilli Revocable Trust	 	 	 	 	 	5,586	 	 	 	 	 	 	 	 	975	 	 	91,633	 	 	 	 
	Gerald A. Casilli	 	 	 	 	 	668	 	 	 	 	 	 	 	 	116	 	 	10,961	 	 	 	 
	Michelle A. Casilli	 	 	 	 	 	668	 	 	 	 	 	 	 	 	116	 	 	10,961	 	 	 	 
	Jamaluddin Moloo	 	 	 	 	 	595	 	 	 	 	 	 	 	 	103	 	 	9,760	 	 	 	 
	Jeanne Haji	 	 	 	 	 	349	 	 	 	 	 	 	 	 	61	 	 	5,741	 	 	 	 
	John Claypool	 	 	 	 	 	454	 	 	 	 	 	 	 	 	79	 	 	7,463	 	 	 	 
	Kenneth Thonton	 	 	 	 	 	 	 	 	15,974	 	 	 	 	 	 	 	 	57,414	 	 	 	 
	Horizon Technology Finance

76 Batterson Park Road

Farmington, CT 06032	 	 	 	 	 	 	 	 	159,744	 	 	 	 	 	 	 	 	 	 	 	 	 

 

 

QuickLinks

Exhibit 4.3

CONVIO, INC. FIFTH AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT April 10, 2007

TABLE OF CONTENTS

CONVIO, INC. FIFTH AMENDED AND RESTATED INVESTORS' RIGHTS AGREEMENT

RECITALS

AGREEMENT

Schedule I SCHEDULE OF COMMON HOLDERS

Schedule II SCHEDULE OF PREFERRED HOLDERS

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00167-of-00352.parquet"}]]